This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

I read with great interest the Commentary "Conflicts of Interest: Science, Money, and Health"¹ published in the March 25, 2002, issue of the ARCHIVES. I agree wholeheartedly that conflicts of interest need to be better clarified for the reader of the medical literature especially when it pertains to industry-sponsored trials. I would, however, like to highlight additional issues that need to be addressed by recommendations governing the publishing of industry-sponsored trials in peer-reviewed journals.

The majority of the issues that I will raise revolve around authorship of the paper. The first fact that must be realized when dealing with an industry-sponsored study is that the sponsor both "holds" and "owns" the data. Typically, academic investigators cited as authors on the manuscript are given the analyses that have been generated by the sponsor to form the results and conclusions section of the manuscript. Less favorable results may or may not be . . . [Full Text of this Article]

RELATED ARTICLE

Conflicts of Interest: Science, Money, and Health
Joseph S. Alpert, Seymour Furman, and Lynn Smaha
Arch Intern Med. 2002;162(6):635-637.
EXTRACT | FULL TEXT